North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic

North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)

The North America non-invasive ventilation masks market is expected to reach US$ 985.8 million by 2028 from US$ 671.1 million in 2021. The market is estimated to grow at a CAGR of 5.6% from 2021 to 2028.

NIV reduces the endotracheal intubation rate, length of hospital stays, complications of mechanical ventilation, and mortality for specific populations, particularly with COPDs. Recent clinical practice guidelines recommend NIV as first-line ventilatory support for treating acute respiratory failure (ARF) in COPDs. Its use has increased in the US. NIV masks are increasingly used to treat people with COPD and respiratory failure. Non-invasive ventilation helps reduce intubation and mortality in patients with COPD exacerbation with respiratory failure. However, the type of mask may impact the success rate. A full-face mask is recommended over nasal masks for patients who are seriously ill and suffer from ARF. The oronasal mask is the most widely used. There is a suggested rotating strategy to change the mask type from time to time. It is unlikely that any mask will prove optimal for all NIV applications. The increasing prevalence of COPDs has significantly raised the need for NIV masks, aiding the North America market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the non-invasive ventilation masks market. The North America non-invasive ventilation masks market is expected to grow at a good CAGR during the forecast period.

North America Non-Invasive Ventilation Masks Market Revenue and Forecast to 2028 (US$ Million)

North America Non-Invasive Ventilation Masks Market Segmentation

By Product

Non-Invasive Ventilation Reusable Masks Non-Invasive Ventilation Disposable Masks

By Application

Chronic Obstructive Pulmonary Diseases Respiratory Dysfunction Pneumonia Others

By End User

Pediatric ICU Home Care Others

By Country

US Canada Mexico

Companies Mentioned

Hamilton Medical Res Med Inc. Fisher & Paykel Healthcare Limited. Air Liquide Medical Systems Dragerwerk AG & Co. KGa A Intersurgical Ltd BMC Medical Co., Ltd De Vilbiss Healthcare LLC VYAIRE MEDICAL, INC. ARMSTRONG MEDICAL Koninklijke Philips N.V.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America non-invasive ventilation masks market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America non-invasive ventilation masks market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.